Log in or register to follow or vote for this project.
Using a Nano-Sized Solution to Solve a Macro-Sized Problem
26 million children are not immunized, exposing them to disabilities or premature death. 2.1 million people die each year from vaccine-preventable diseases (World Health Organization (WHO)). People living in hard-to-reach areas of the world struggle to receive immunization. Nanoly's technology enables cheap, convenient, and safe delivery of vaccines to anywhere in the world. We are developing a nanoparticle based chemical shield that protects the vaccine for improved storage and transportation without refrigeration.
The Problem: Vaccines are sensitive to heat and must remain refrigerated
The vaccine "cold chain" is the system of transporting and storing vaccines within the temperature range of 35°F (2°C) to 45°F (8°C) (US Department of Health and Human Services). If exposed to temperatures too high or too low, the vaccine will spoil (or denature) and become inactive. The places that lack proper immunization have limited to no electricity supply to maintain the vaccine cold chain.
Our Solution: NanoShield
NanoShield is composed of a unique polymer consisting of nontoxic nanoparticles and a hydrogel. When this polymer is mixed with a nontoxic buffer agent and the vaccine's proteins, the proteins are encapsulated into the polymer. The polymer insulates the proteins, enabling the vaccine to remain active and ready to use when needed. 82% of the Papua New Guinea's population live in rural areas. This contributes to why the country has one of the lowest immunization rates in the world. Our product is designed to help deliver vaccines to the hard to reach populations.
Our Social Value
Because of the increased costs of delivering vaccines, UNICEF estimates that an additional US$ 1 billion in financing is necessary every year to meet international goals of improving immunizations access and reducing child mortality in the poorest nations. We are the solution to abolish that funding gap.
- We eliminate the need for expensive refrigerators, which drastically reduces complications in delivery logistics for primary care providers
- We mitigate problems associated with vaccine spoilage, including shortages in times of need
- We allow flex-volume orders so that bootstrapped non-profit health groups can afford to deliver vaccine to small communities